Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden
· Delayed Price · Currency is SEK 9.86
-0.39 (-3.80%)
Apr 29, 2026, 5:14 PM CET
-60.36% (1Y)
| Market Cap | 211.20M |
| Revenue (ttm) | 152.35M |
| Net Income (ttm) | 127.24M |
| Shares Out | 20.61M |
| EPS (ttm) | 7.74 |
| PE Ratio | 1.66 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 29,892 |
| Average Volume | 73,641 |
| Open | 10.30 |
| Previous Close | 10.25 |
| Day's Range | 9.52 - 10.70 |
| 52-Week Range | 5.42 - 38.10 |
| Beta | 0.52 |
| RSI | 65.60 |
| Earnings Date | Mar 31, 2026 |